News from us and our partners
Tags
Topics
0 results
Amolyt Pharma announces research agreement and licensing option with XOMA
Julier Medical raises €3 million in seed financing from Sofinnova Partners to treat patients with acute ischemic stroke
PinCell announces the development of a key transgenic mouse model and the appointment of Dr. Antonino Amato as CEO
Shockwave Medical announces agreement to acquire Neovasc
AFYREN adds new hires to support growth in France and expansion abroad
CinCor Pharma to be acquired by AstraZeneca
Sofinnova Partners Chair sees opportunity on the horizon
Amolyt Pharma announces $138 million Series C financing led by Sofinnova Partners and co-led by Intermediate Capital Group
Sofinnova Partners welcomes Mano Iyer as Venture Partner
Inspirna announces interim data from Phase 1b/2 study of Abequolixron (RGX-104) in relapsed or refractory lung cancer
MaxCyte signs strategic platform license with Catamaran Bio to support its CAR-NK cell therapy programs
Lilly and ProQR to expand RNA editing collaboration
Elicit Plant awarded up to €7.5 M funding from the European Commission through the EIC Accelerator program for deep tech start-ups
May Health completes treatment of five participants in U.S. feasibility study of its Ovarian Rebalancing treatment for PCOS-related infertility
AAVantgarde Founder and Chief Scientific Officer, Professor Alberto Auricchio, is elected as Vice President of the European Society of Gene and Cell Therapy